Basimglurant Sulfate

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameBasimglurant Sulfate
Drug Alias Name贝昔谷兰basimglurantumbasimglurant巴辛谷兰RO-4917523 +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMetabotropic glutamate receptor 5 antagonists
TargetsMetabotropic glutamate receptor 5
Therapy Area/IndicationsDepressive Disorder, MajorDepressionFragile X Syndrome +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesSweden +[22] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNoema Pharma AG
Inactive CompaniesF. Hoffmann-La Roche Ltd
Active IndicationsTrigeminal NeuralgiaTuberous Sclerosis
Inactive IndicationsDepressive Disorder, MajorDepressionFragile X Syndrome

Other Information

ATC CodeN/A
Related LinksWikipedia